Fondaparinux Sodium 55111-0681-02
- Manufacturer
- Dr. Reddy's Laboratories Limited
- Dosage Form
- Injection
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- July 14, 2011
- Listing Expires
- December 31, 2026
- Application
- ANDA091316
Need to source Fondaparinux Sodium? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Fondaparinux Sodium | 10 mg/.8mL |
Drug Class
Factor Xa Inhibitor [EPC]Factor Xa Inhibitors [MoA]
Selected Package
55111-0681-02Selected2 SYRINGE in 1 CARTON (55111-681-02) / .8 mL in 1 SYRINGE (55111-681-11)
Other packages for this product(1)
10 SYRINGE in 1 CARTON (55111-681-10) / .8 mL in 1 SYRINGE (55111-681-11)